Taking all together, modulation of central as well as peripheral TRPA1 channels can be a novel therapeutic strategy to protect against metabolic adversities associated with NPDs, out of which the major ones are weight gain and diabetes. This evidence concerns the gene TRPA1 and diabetes mellitus.